Skip to main content
Retour
Watch Compare

Envoy Medical, Inc.

Qualité des données : 100%
Également cotée sous COCHW Nasdaq
COCH
Nasdaq Manufacturing Measuring & Analyzing Instruments
0,64 €
▼ 0,02 € (-3,47%)
Cap. Boursière: 49,20 M
Prix
0,64 €
Cap. Boursière
49,20 M
Fourchette du Jour
0,64 € — 0,67 €
Fourchette 52 Semaines
0,36 € — 1,91 €
Volume
107 773
Ouverture 0,67 €
Moyenne 50J / 200J
0,68 €
6,35% below
Moyenne 50J / 200J
0,96 €
33,58% below

Quick Summary

Points Clés

Negative free cash flow of -18,38 M
Capital intensive — 74,27% of revenue goes to capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)7,11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-3219,27%
Net Margin-9857,26%
Op. Margin-9240,66%

Sécurité

Debt / Equity
N/A
Current Ratio0,64
Interest Coverage-14,01

Valorisation

PE (TTM)
-2,07
En dessous de la moyenne du secteur (-1,98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (44 pairs)
Métrique Action Médiane du Secteur
P/E -2,1 -2,0
P/B — 5,1
ROE % — -51,0
Net Margin % -9857,3 -150,2
Rev Growth 5Y % — 9,3
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 7,11% Revenue Growth (3Y) -12,67%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 241 000,0 Net Income (TTM) -23,76 M
ROE N/A ROA -262,77%
Gross Margin N/A Operating Margin -9240,66%
Net Margin -9857,26% Free Cash Flow (TTM) -18,38 M
ROIC -3219,27% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,64
Interest Coverage -14,01 Asset Turnover 0,03
Working Capital -3,23 M Tangible Book Value -7,66 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,07 Forward P/E N/A
P/B Ratio N/A P/S Ratio 204,17
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -37,35%
Market Cap 49,20 M Enterprise Value 49,20 M
Per Share
EPS (Diluted TTM) -1,23 Revenue / Share 0,00
FCF / Share -0,24 OCF / Share -0,24
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 74,27% FCF Conversion 77,37%
SBC-Adj. FCF -19,00 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 241 000,0 225 000,0 316 000,0 — —
Net Income -23,76 M -20,80 M -29,91 M 19,23 M -251 633,0
EPS (Diluted) -1,23 -1,49 -2,38 — —
Gross Profit — — — — —
Operating Income -22,27 M -19,26 M -18,37 M -4,89 M -5,20 M
EBITDA — — — — —
R&D Expenses 12,49 M 10,18 M 8,96 M — —
SG&A Expenses — — 7,28 M — —
D&A — — — — —
Interest Expense 1,59 M 816 000,0 — — —
Income Tax — — — 1,50 M —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,56 M 11,54 M 7,64 M 430,62 M 426,90 M
Total Liabilities 20,33 M 30,38 M 9,40 M 18,79 M 38,62 M
Shareholders' Equity -12,16 M -18,84 M -1,76 M -17,91 M -36,71 M
Total Debt — — — — —
Cash & Equivalents — — 4,22 M 107 773,0 149 845,0
Current Assets 6,28 M 9,38 M 6,83 M 220 422,0 863 167,0
Current Liabilities 11,56 M 7,54 M 6,64 M 7,31 M 2,68 M